G. G. Kaplan and S. C. Ng, Understanding and Preventing the Global Increase of Inflammatory Bowel Disease, Gastroenterology, vol.152, pp.313-321, 2017.

H. S. Souza and C. Fiocchi, Immunopathogenesis of IBD: current state of the art, Nat. Rev. Gastroenterol. Hepatol, vol.13, pp.13-27, 2016.

G. Bamias, T. T. Pizarro, and F. Cominelli, Pathway-based approaches to the treatment of inflammatory bowel disease, Transl. Res. J. Lab. Clin. Med, vol.167, pp.104-115, 2016.

L. E. Targownik, Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis

, Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc, vol.15, p.1, 2017.

J. Colombel, N. Narula, and L. Peyrin-biroulet, Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases, Gastroenterology, vol.152, p.5, 2017.

L. Pouillon, P. Bossuyt, and L. Peyrin-biroulet, Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease, Expert Opin. Biol. Ther, vol.16, pp.1277-1290, 2016.

S. Bongarzone, V. Savickas, F. Luzi, and T. Gee, Targeting the Receptor for Advanced Glycation Endproducts (RAGE), J. Med. Chem, 2017.

C. Bopp, Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis, Crit. Care Lond. Engl, vol.12, p.201, 2008.

E. Boulanger, AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression, Kidney Int, vol.61, pp.148-156, 2002.

M. Butscheid, P. Hauptvogel, P. Fritz, U. Klotz, and D. M. Alscher, Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease, J. Clin. Pathol, vol.60, pp.415-418, 2007.

A. M. Schmidt, S. D. Yan, S. F. Yan, and D. M. Stern, The biology of the receptor for advanced glycation end products and its ligands, Biochim. Biophys. Acta, vol.1498, pp.99-111, 2000.

A. M. Schmidt, Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface, J. Biol. Chem, vol.267, pp.14987-14997, 1992.

S. Du-yan, Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease, Proc. Natl. Acad. Sci. U. S. A, vol.94, pp.5296-5301, 1997.

O. Hori, The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system, J. Biol. Chem, vol.270, pp.25752-25761, 1995.

M. A. Hofmann, RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides, Cell, vol.97, pp.889-901, 1999.

S. Ahmad, RAGEs and s-RAGE; friend or foe for cancer, Semin. Cancer Biol, 2017.

R. Ramasamy, A. Shekhtman, and A. M. Schmidt, The multiple faces of RAGE -opportunities for therapeutic intervention in aging and chronic disease, Expert Opin. Ther. Targets, vol.20, pp.431-446, 2016.

R. Ray, J. K. Juranek, and V. Rai, RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis, Neurosci. Biobehav. Rev, vol.62, pp.48-55, 2016.